Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
192
394
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Diagnos Laboratorium Utama PT Tbk
Other Long-Term Assets
Diagnos Laboratorium Utama PT Tbk
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
|
Other Long-Term Assets
Rp5.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
139%
|
CAGR 10-Years
N/A
|
|
|
Prodia Widyahusada Tbk PT
IDX:PRDA
|
Other Long-Term Assets
Rp27.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
Diagnos Laboratorium Utama PT Tbk
Glance View
PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. The company employs 54 full-time employees The company went IPO on 2021-01-15. The firm is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouses, eye banks, sperm banks and blood banks, organ transplant banks, and other medical support services. The company operates through providing health services using laboratories segment. The Company’s products and services include clinical pathology laboratory, anatomy pathology laboratory, genomic laboratory, homecare health services, corporate health services, and Covid-19 checkup. The firm serves markets, such as Jakarta, Depok, Bali, Bandung, Bekasi, Padang, Makassar, Tangerang Selatan, Dumai, Batam, Purwakarta, Karawang, and Brebes. The company has branch offices in Ciputat (South Tangerang), Denpasar (Bali), Padang (West Sumatra), and Makassar, South Sulawesi.
See Also
What is Diagnos Laboratorium Utama PT Tbk's Other Long-Term Assets?
Other Long-Term Assets
5.8B
IDR
Based on the financial report for Dec 31, 2023, Diagnos Laboratorium Utama PT Tbk's Other Long-Term Assets amounts to 5.8B IDR.
What is Diagnos Laboratorium Utama PT Tbk's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
139%
Over the last year, the Other Long-Term Assets growth was 79%. The average annual Other Long-Term Assets growth rates for Diagnos Laboratorium Utama PT Tbk have been -8% over the past three years , 139% over the past five years .
You don't have any saved screeners yet
